Experimental Study on XRSJ in Treating Mammary Gland Hyperplasia Rabbits

CHEN Xi,CHEN Cui-cui,GUO Bao-liang,PANG Jing-wen,YANG Xue-wei,ZHANG Dong-wei,YAN Zhao-qi,SHEN Bin,ZHONG Lei,QIN You-you,ZHANG Jian-guo
DOI: https://doi.org/10.13241/j.cnki.pmb.2012.32.035
2012-01-01
Abstract:Objective:To observe the effect of XRSJ on mammary gland hyperplasia in rabbits and to explore its mechanism.Methods:90 rabbits were divided into the high(A),medium(B) and low(C) dose of XRSJ,the Xiao yao Pill(D),the model(E) and the normal control group(F) with 15 rabbits in each group.The former 5 groups were injected with diethylstilbestrol and progesterone intramuscularly for one month to induce the hyperplasia model and then given respective medicines via gastrogavage for 3 months.The height of mammary gland were monitored by vernier micrometer.The changes in morphology of mammary gland were observed using light and electronic microscope.The levels of estradiol(E2) were measured by radioimmuno assay before,at the end of and 3 months after the treatment.Results:Compared with those before treatment and those in the model group,in the high and medium dose of XRSJ groups after treatment,obvious decrease of number in hyperplastic lobuli mammae,layers of glandular epithelium cells,connective tissues and organelles were seen with partial of hyperplastic cell apoptosis in them.Besides,the serum E2 level decreased obviously(P<0.05).Three months later,all the above index maintained stable without rebound.Conclusion:Treatment of XRSJ could alleviate the hyperplasia of mammary glands,reduce E2 level in mammary gland hyperplasia rabbits,showing a significant the rapeutical effect.
What problem does this paper attempt to address?